← All Sponsors
SPONSOR

Jiangsu Province Nanjing Brain Hospital

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: NSCLC
NCT06339242 Phase 2
Recruiting

A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis

NSCLC
China View Trial →